Higher Cholesterol levels in blood.

Phase 3

• Conditions: Health Condition 1: E784- Other hyperlipidemia

• Registration Number: CTRI/2024/05/067265
• Lead Sponsor: andini RD

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients of all genders between the age group of 20-65 years who fulfil the criteria of Objective and Subjective parameters.

2.Controlled HTN -less than or equal to 140/90 mm of Hg.

3.Controlled NIDDM -HbA1C less than or equal to 7%.

4.Patients fulfilling the diagnostic criteria of Hyperlipidaemia.

5.Patients already on Antilipidemic drugs since 0-10years.

6.Patients fit for Nitya Virechana.

Exclusion Criteria

1.Patients newly diagnosed and not on Antilipidemic drugs.

2.Induced Hyperlipidaemia due to prolonged intake of Glucocortiosteriods.

3.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders, CKD, Nephrotic Syndrome, Liver disorders etc.)

4.Patients with a past history of Atrial Fibrillation, Acute Coronary Syndrome,

5.Patient with evidence of malignancy.

6.Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in Cholesterol levelsTimepoint: 45days

Secondary Outcome Measures

Name	Time	Method
Weight lossTimepoint: 45days